Evidence map›Paper›PMID 20652055›Full record

ArticleMediators of inflammation2010

Rhizoma Coptidis inhibits LPS-induced MCP-1/CCL2 production in murine macrophages via an AP-1 and NFkappaB-dependent pathway.

Andrew Remppis, Florian Bea, Henry Johannes Greten, Annette Buttler, Hongjie Wang, Qianxing Zhou, Michael R Preusch, Ronny Enk, Robert Ehehalt, Hugo Katus and 1 more

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 66 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Puerarin Prevents Acute Liver InjuryFrontiers in pharmacology · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Andrew RemppisMedizinische Klinik III, Universität Heidelberg, 69120 Heidelberg, Germany.
Florian Bea
Henry Johannes Greten
Annette Buttler
Hongjie Wang
Qianxing Zhou
Michael R Preusch
Ronny Enk
Robert Ehehalt
Hugo Katus
Erwin Blessing
Heidelberg University · DEDeutsche Gesellschaft für Traditionelle Chinesische Medizin · DEUniversity of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe Chinese extract Rhizoma coptidis is well known for its anti-inflammatory, antioxidative, antiviral, and antimicrobial activity. The exact mechanisms of action are not fully understood.

methodsWe examined the effect of the extract and its main compound, berberine, on LPS-induced inflammatory activity in a murine macrophage cell line. RAW 264.7 cells were stimulated with LPS and incubated with either Rhizoma coptidis extract or berberine. Activation of AP-1 and NFkappaB was analyzed in nuclear extracts, secretion of MCP-1/CCL2 was measured in supernatants.

resultsIncubation with Rhizoma coptidis and berberine strongly inhibited LPS-induced monocyte chemoattractant protein (MCP)-1 production in RAW cells. Activation of the transcription factors AP-1 and NFkappaB was inhibited by Rhizoma coptidis in a dose- and time-dependent fashion.

conclusionsRhizoma coptidis extract inhibits LPS-induced MCP-1/CCL2 production in vitro via an AP-1 and NFkappaB-dependent pathway. Anti-inflammatory action of the extract is mediated mainly by its alkaloid compound berberine.

Indexed as

AnimalsAnti-Inflammatory AgentsBerberineCells, CulturedChemokine CCL2Coptis chinensisDrugs, Chinese HerbalInterleukin-12Interleukin-1betaLipopolysaccharidesMacrophagesMiceNF-kappa BNitric OxideReactive Oxygen SpeciesTranscription Factor AP-1Anti-Inflammatory AgentsBerberineCcl2 protein, mouseChemokine CCL2Coptidis rhizoma extractDrugs, Chinese HerbalInterleukin-12Interleukin-1betaLipopolysaccharidesNF-kappa BNitric OxideReactive Oxygen SpeciesTranscription Factor AP-1

Identifiers

PMID20652055
PMCPMC2905940
OpenAlexW2067105764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.